Skip to content
Latest
STOX.NEWS
In focus

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock closed at a record high.

Image supplied by MarketWatch.
Advertisement
Demo creative for ADG7 Article top (728x90)

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

Advertisement
Demo creative for ADG8 Article body (336x280)

More on this